Article
The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation
1 Sept 2021
Abstract excerpt
Type I Interferons (IFNs) are key regulators of natural and therapy-induced host defense against viral infection and cancer. Several years of remarkable progress in the field of oncoimmunology have revealed the dual nature of these cytokines. Hence, Type I IFNs may trigger anti-tumoral responses, while leading immune dysfunction and disease progression. This dichotomy relies on the duration and intensity of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
